NMDAR hypofunction is believed to be involved in the pathophysiology of schizophrenia and genetic, biochemical, and pharmacological evidence documents reduced expression of particular subunits of the receptor, including GluN1, in the brains of individuals with schizophrenia16–21. Here, GRIN1 is linked to schizophrenia.